Replies to post #151756 on Biotech Values

[jq1234]

BMRN: The data looked really good. Even every other week dosing showed trend of improvement over time.

I didn't have time to listen to CC. Did they say they are going to submit BLA/MAA in 1Q2013 based on data they have now or they'll need full data at least from extension at 36-week and/or 48-week?